Cancer News and Research

Latest Cancer News and Research

TechniScan becomes publicly traded company through reverse merger with Castillo

TechniScan, Inc. (OTCBB: TSNI) (“TechniScan” or the “Company”), a medical device company engaged in the development and commercialization of an automated breast ultrasound imaging system, has become a publicly traded company through a reverse merger with and into Castillo, Inc., a Delaware corporation.

20 Oct 2009

TechnoVax receives NIH grant to further the development of its VLP-based, vaccine program

TechnoVax, Inc., a biotechnology developer of novel vaccines was awarded a three-year $2.9 million SBIR phase II grant from the National Institutes of Health to further the development of its VLP-based, vaccine program.

20 Oct 2009

Alberta revises its cervical cancer screening guideline

Alberta has revised its Cervical Cancer Screening Clinical Practice Guideline (CPG) based on new technologies and epidemiologic evidence from Alberta and internationally.

20 Oct 2009

NCCN Guidelines for Acute Myeloid Leukemia updated

The National Comprehensive Cancer Network (NCCN) recently made updates to the NCCN Clinical Practice Guidelines in Oncology(TM) for Acute Myeloid Leukemia, a cancer that starts inside the bone marrow and the most common acute leukemia affecting adults.

20 Oct 2009

PhRMA calls for appropriate incentives for continued biotechnology innovation

Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson issued the following statement today regarding appropriate incentives for continued biotechnology innovation:

20 Oct 2009

Novartis' Tasigna capsules meets primary endpoint in comparison trial with Gleevec

Novartis announced today that Tasigna (nilotinib) 200 mg capsules met its primary endpoint in the first head-to-head comparison with the company's groundbreaking drug Gleevec (imatinib mesylate) tablets*. Tasigna produced faster and deeper responses than Gleevec when given as first-line therapy for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. Tasigna was well tolerated in the study.

20 Oct 2009

Bristol-Myers Squibb presents study data on ORENCIA for treating rheumatoid arthritis

Bristol-Myers Squibb Company today announced two-year results of a study that supports use of ORENCIA® (abatacept) for methotrexate-naive patients with moderate to severe rheumatoid arthritis of less than or equal to two years duration.

20 Oct 2009

SIMPONI treatment results in greater inhibition of structural damage in arthritis patients

Phase 3 data reported for the first time show that once every four week subcutaneous injections of SIMPONI(TM) (golimumab) resulted in significantly greater inhibition of structural damage compared with placebo plus methotrexate in patients with active rheumatoid arthritis (RA) and active psoriatic arthritis (PsA).

20 Oct 2009

ImmunoCellular Therapeutics files a provisional patent application

ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company that is developing immune-based therapies for the treatment of brain and other cancers, announced today that it has filed a provisional patent application at US Patent Office seeking protection of intellectual property relating to novel glycosylated epitopes present in lung cancer, pancreatic cancer and colon cancer that are targeted by the Company’s ICT-109 monoclonal antibody product candidate.

20 Oct 2009

Clonality analyses may lead to further understanding of hepatocarcinogenesis

Focal nodular hyperplasia (FNH) is a lesion found in an otherwise normal liver, and is considered to be parenchyma overgrowth responsive to increased blood flow secondary to vascular malformations.

20 Oct 2009

Alabama Supreme Court rules in favor of Novartis Pharmaceuticals

The Alabama Supreme Court today overturned a jury verdict against Novartis Pharmaceuticals Corporation (NPC), and directed entry of judgment in favor of NPC. NPC is pleased that the Alabama Supreme Court has found in our favor, which demonstrates that the State of Alabama's claims were unfounded.

20 Oct 2009

Regulatory differences between mother and daughter cells shed new light on cell division

When mother and daughter cells are created each time a cell divides, they are not exactly alike. They have the same set of genes, but differ in the way they regulate them. New research now reveals that these regulatory differences between mother and daughter cells are directly linked to how they prepare for their next split.

20 Oct 2009

CMS requested for coverage of two FDG PET scans during the initial treatment

Seven medical imaging groups wrote a joint letter to the Centers for Medicare and Medicaid Services (CMS) to formally request coverage of two fluorodeoxyglucose (FDG) positron emission tomography (PET) scans for a patient during the initial treatment evaluation. Currently, CMS covers only one FDG-PET study during initial treatment-a limitation that the groups believe is contrary to good clinical practice under certain circumstances.

20 Oct 2009

Gastrointestinal Associates emphasizes the need for colon screenings

As Washington policymakers debated health care reform on weekend talk shows, 48 people who are out of work or without health insurance received free colonoscopy screenings at Gastrointestinal Associates (GIA) here.

20 Oct 2009

Vitamin D and progesterone combination for treating traumatic brain injury

As doctors begin to test progesterone for traumatic brain injury at sites across the country, researchers are looking ahead to optimizing the hormone's effectiveness.

20 Oct 2009

Health Discovery Corporation granted additional patents for Recursive Feature Elimination using Support Vector Machines

Health Discovery Corporation is pleased to announce numerous additional issued patents and Notices of Allowance since its last press release describing its intellectual property portfolio. The Company now has a total of 37 issued patents, 4 Notices of Allowance and 30 pending patent applications.

20 Oct 2009

Testicular cancer survivors at risk of effective treatment

Testicular cancer survivors can face an increased risk of long-term illness, not because of the malignancy, but the highly effective treatment they receive, according to a study in the urology journal BJUI.

20 Oct 2009

Seguro Surgical obtains global marketing rights to use a novel abdominal surgery device

Seguro Surgical, Inc., a medical device development company specializing in the commercialization of surgical instrumentation, today announced that it has acquired, from The Johns Hopkins University, the global marketing rights to a novel device for use in abdominal surgery.

20 Oct 2009

Highly educated women deal less well with psychological aspects of breast cancer

Well-educated women and those who live alone are emotionally the hardest hit by breast cancer, according to the findings of a new Australian study announced during October's Breast Cancer Awareness Month.

20 Oct 2009

Tempur-Pedic Hugs Back campaign to help fund research for pancreatic cancer

Tempur-Pedic International Inc. (NYSE: TPX), the leading manufacturer, marketer and distributor of premium mattresses and pillows worldwide, today announces the Tempur-Pedic Hugs Back campaign, featuring a limited edition version of the company's popular My Tempur-Pedic Teddy Bear®.

20 Oct 2009

Cancer News and Research

Latest Cancer News and Research

TechniScan becomes publicly traded company through reverse merger with Castillo

TechnoVax receives NIH grant to further the development of its VLP-based, vaccine program

Alberta revises its cervical cancer screening guideline

NCCN Guidelines for Acute Myeloid Leukemia updated

PhRMA calls for appropriate incentives for continued biotechnology innovation

Novartis' Tasigna capsules meets primary endpoint in comparison trial with Gleevec

Bristol-Myers Squibb presents study data on ORENCIA for treating rheumatoid arthritis

SIMPONI treatment results in greater inhibition of structural damage in arthritis patients

ImmunoCellular Therapeutics files a provisional patent application

Clonality analyses may lead to further understanding of hepatocarcinogenesis

Alabama Supreme Court rules in favor of Novartis Pharmaceuticals

Regulatory differences between mother and daughter cells shed new light on cell division

CMS requested for coverage of two FDG PET scans during the initial treatment

Gastrointestinal Associates emphasizes the need for colon screenings

Vitamin D and progesterone combination for treating traumatic brain injury

Health Discovery Corporation granted additional patents for Recursive Feature Elimination using Support Vector Machines

Testicular cancer survivors at risk of effective treatment

Seguro Surgical obtains global marketing rights to use a novel abdominal surgery device

Highly educated women deal less well with psychological aspects of breast cancer

Tempur-Pedic Hugs Back campaign to help fund research for pancreatic cancer

Cancer Research - Second Edition eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in